tiprankstipranks
Trending News
More News >
Cardio Diagnostics Holdings (CDIO)
NASDAQ:CDIO
US Market

Cardio Diagnostics Holdings (CDIO) Price & Analysis

Compare
260 Followers

CDIO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.09%0.78%0.09%94.59%
0.09% Other Institutional Investors
94.59% Public Companies and Individual Investors

CDIO FAQ

What was Cardio Diagnostics Holdings’s price range in the past 12 months?
Cardio Diagnostics Holdings lowest stock price was $3.40 and its highest was $53.10 in the past 12 months.
    What is Cardio Diagnostics Holdings’s market cap?
    Cardio Diagnostics Holdings’s market cap is $6.76M.
      When is Cardio Diagnostics Holdings’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Cardio Diagnostics Holdings’s earnings last quarter?
      Currently, no data Available
      Is Cardio Diagnostics Holdings overvalued?
      According to Wall Street analysts Cardio Diagnostics Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Cardio Diagnostics Holdings pay dividends?
        Cardio Diagnostics Holdings does not currently pay dividends.
        What is Cardio Diagnostics Holdings’s EPS estimate?
        Cardio Diagnostics Holdings’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Cardio Diagnostics Holdings have?
        Cardio Diagnostics Holdings has 1,738,710 shares outstanding.
          What happened to Cardio Diagnostics Holdings’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Cardio Diagnostics Holdings?
          Currently, no hedge funds are holding shares in CDIO

          Company Description

          Cardio Diagnostics Holdings

          Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
          Similar Stocks
          Company
          Price & Change
          Follow
          NanoViricides
          Tenax Therapeutics
          Ovid Therapeutics
          CalciMedica
          Longeveron
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis